Skip to main content
. 2023 Apr 12;616(7957):525–533. doi: 10.1038/s41586-023-05783-5

Extended Data Fig. 5. Overview of number of regions sampled, stage, treatment and ITH metrics including mutational ITH, SCNA ITH and whole genome doubling status for 432 tumours from 421 patients in TRACERx.

Extended Data Fig. 5

Each tumour is arranged vertically ordered first by pathological stage then by fraction of subclonal subclonal mutations. LCNEC = Large cell neuroendocrine carcinoma, CN = copy number.